![](/images/general/no_picture/200_user.png)
Kevin Chou
Examiner (ID: 9940)
Most Active Art Unit | 3785 |
Art Unit(s) | 3785 |
Total Applications | 4 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12588846
[patent_doc_number] => 20180088111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => IMMUNOASSAY FOR SOLUBLE PROGRAMMED DEATH-1 (sPD-1) PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/565525
[patent_app_country] => US
[patent_app_date] => 2016-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565525
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565525 | IMMUNOASSAY FOR SOLUBLE PROGRAMMED DEATH-1 (sPD-1) PROTEIN | Apr 11, 2016 | Abandoned |
Array
(
[id] => 12603087
[patent_doc_number] => 20180092859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => A Supramolecular Chitosan Complex Drug Delivery Platform
[patent_app_type] => utility
[patent_app_number] => 15/562526
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562526
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562526 | A Supramolecular Chitosan Complex Drug Delivery Platform | Mar 30, 2016 | Abandoned |
Array
(
[id] => 13343657
[patent_doc_number] => 20180223368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => METHODS FOR DIAGNOSING AND TREATING FOLLICULAR LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 15/559046
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559046 | METHODS FOR DIAGNOSING AND TREATING FOLLICULAR LYMPHOMA | Mar 16, 2016 | Abandoned |
Array
(
[id] => 11085378
[patent_doc_number] => 20160282340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION'
[patent_app_type] => utility
[patent_app_number] => 15/073249
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 204
[patent_figures_cnt] => 204
[patent_no_of_words] => 63276
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15073249
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/073249 | Activation of bioluminescence by structural complementation | Mar 16, 2016 | Issued |
Array
(
[id] => 13890019
[patent_doc_number] => 10197556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Methods to detect non-genotoxic carcinogens using flatworms
[patent_app_type] => utility
[patent_app_number] => 15/557930
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9749
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557930 | Methods to detect non-genotoxic carcinogens using flatworms | Mar 14, 2016 | Issued |
Array
(
[id] => 14627405
[patent_doc_number] => 20190227070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY
[patent_app_type] => utility
[patent_app_number] => 16/328214
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328214 | KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY | Mar 9, 2016 | Abandoned |
Array
(
[id] => 11678595
[patent_doc_number] => 09677113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Resonance energy transfer assay with cleavage sequence and spacer'
[patent_app_type] => utility
[patent_app_number] => 15/064379
[patent_app_country] => US
[patent_app_date] => 2016-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 17910
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15064379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/064379 | Resonance energy transfer assay with cleavage sequence and spacer | Mar 7, 2016 | Issued |
Array
(
[id] => 10823613
[patent_doc_number] => 20160169777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'IN SITU HEAT INDUCED ANTIGEN RECOVERY AND STAINING APPARATUS AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/050132
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 44346
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050132 | In situ heat induced antigen recovery and staining apparatus and method | Feb 21, 2016 | Issued |
Array
(
[id] => 11041646
[patent_doc_number] => 20160238602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'METHOD FOR DETECTING PROTEINS BY MEANS OF APTAMERS'
[patent_app_type] => utility
[patent_app_number] => 15/042732
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8246
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15042732
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/042732 | Method for detecting proteins by means of aptamers | Feb 11, 2016 | Issued |
Array
(
[id] => 11041661
[patent_doc_number] => 20160238617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'DIAGNOSTIC REAGENTS AND METHODS SPECIFIC TO INNER EAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/041156
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041156
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041156 | Diagnostic reagents and methods specific to inner ear disorders | Feb 10, 2016 | Issued |
Array
(
[id] => 14537403
[patent_doc_number] => 20190204323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => BIOMARKERS FOR PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 15/548240
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548240
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548240 | Biomarkers for pancreatic cancer | Feb 4, 2016 | Issued |
Array
(
[id] => 10815345
[patent_doc_number] => 20160161505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1'
[patent_app_type] => utility
[patent_app_number] => 15/017140
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5270
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017140
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/017140 | DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1 | Feb 4, 2016 | Abandoned |
Array
(
[id] => 11278123
[patent_doc_number] => 09494601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Atypical hemolytic uremic syndrome (AHUS) biomarker proteins'
[patent_app_type] => utility
[patent_app_number] => 15/013833
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 76
[patent_no_of_words] => 45335
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/013833 | Atypical hemolytic uremic syndrome (AHUS) biomarker proteins | Feb 1, 2016 | Issued |
Array
(
[id] => 10792983
[patent_doc_number] => 20160139139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Systems and Methods for Developing Diagnostic Tests Based on Biomarker Information from Legacy Clinical Sample Sets'
[patent_app_type] => utility
[patent_app_number] => 15/007786
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12903
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/007786 | Systems and Methods for Developing Diagnostic Tests Based on Biomarker Information from Legacy Clinical Sample Sets | Jan 26, 2016 | Abandoned |
Array
(
[id] => 11464981
[patent_doc_number] => 09581606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood'
[patent_app_type] => utility
[patent_app_number] => 15/003501
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 14668
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003501 | Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood | Jan 20, 2016 | Issued |
Array
(
[id] => 15102597
[patent_doc_number] => 10472599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Microfluidic cell culture of patient-derived tumor cell spheroids
[patent_app_type] => utility
[patent_app_number] => 15/540346
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11272
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540346
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540346 | Microfluidic cell culture of patient-derived tumor cell spheroids | Jan 6, 2016 | Issued |
Array
(
[id] => 10777841
[patent_doc_number] => 20160123996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 14/987569
[patent_app_country] => US
[patent_app_date] => 2016-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 80
[patent_no_of_words] => 21611
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987569
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987569 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Jan 3, 2016 | Abandoned |
Array
(
[id] => 10807847
[patent_doc_number] => 20160154006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Absolute Quantitation of Proteins and Protein Modifications by Mass Spectrometry with Multiplexed Internal Standards'
[patent_app_type] => utility
[patent_app_number] => 14/980155
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 24549
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980155 | Absolute Quantitation of Proteins and Protein Modifications by Mass Spectrometry with Multiplexed Internal Standards | Dec 27, 2015 | Abandoned |
Array
(
[id] => 12588915
[patent_doc_number] => 20180088134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Compilation of Detection Reagents, In-Vitro Method for Detecting Mutated Leptin, and Use of a Detection Reagent
[patent_app_type] => utility
[patent_app_number] => 15/558322
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558322
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558322 | Compilation of detection reagents, in-vitro method for detecting mutated leptin, and use of a detection reagent | Dec 22, 2015 | Issued |
Array
(
[id] => 10745353
[patent_doc_number] => 20160091502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'Fibrosis Biomarker Assay'
[patent_app_type] => utility
[patent_app_number] => 14/960713
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38750
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/960713 | Fibrosis biomarker assay | Dec 6, 2015 | Issued |